{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:14:05Z","timestamp":1779311645875,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Pigmentation varies widely in cutaneous melanoma, but its clinicopathologic and immunologic implications are incompletely defined. We retrospectively reviewed 627 patients with stage II\u2013III melanoma treated at H. Lee Moffitt Cancer Center (2010\u20132019) and correlated pathologist-graded tumor pigmentation (0\u20133) with tumor features and sentinel lymph node biopsy results. We then evaluated transcript levels of pigmentation markers (TYR, DCT, MITF) for associations with overall survival (OS), tumor microenvironment (TME) composition, and immune checkpoint inhibitor (ICI) response using TCGA-SKCM bulk RNA-seq (n = 443) and public cohorts (GSE91061, GSE115978, GSE120575). Pigmented tumors (74.2%) showed lower Breslow depth (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.001), more tumor-infiltrating lymphocytes (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001), greater angiolymphatic invasion (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.03), enrichment for superficial spreading subtype (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001), and higher sentinel lymph node biopsy positivity (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.05) versus nonpigmented tumors. In TCGA, high TYR, DCT, and MITF expression independently correlated with worse OS. xCell analysis showed that low expression groups were enriched for multiple effector T- and B-cell populations, whereas high expression associated with immunosuppressive cell types (e.g., M2 macrophages, Tregs). In an ICI-treated cohort (GSE91061), baseline MITF was higher in nonresponders (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.023). Single-cell analyses confirmed pigmentation gene expression in malignant cells and demonstrated elevated MITF within myeloid subsets of nonresponders. Overall, both histologic pigmentation and pigmentation-gene signatures associate with tumor characteristics, immune contexture, and clinical outcomes, suggesting potential utility for risk stratification and treatment response prediction.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000003223","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:02:00Z","timestamp":1774036920000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of Melanoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Helana","family":"Ghali","sequence":"first","affiliation":[{"name":"University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayah N.","family":"Al-Bzour","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena","family":"Boby","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaliz","family":"Aflatooni","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle K.","family":"DePalo","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Dugan","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Department of Medical Education, University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mhaskar","sequence":"additional","affiliation":[{"name":"Department of Medical Education, University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Zager","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon K.","family":"Sondak","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Premi","sequence":"additional","affiliation":[{"name":"Department of Tumor Microenvironment and Metastasis (TMEM), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Storkus","sequence":"additional","affiliation":[{"name":"Departments of Immunology and Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Messina","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilit","family":"Karapetyan","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Immuno-oncology program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00059.2017","article-title":"Melanosomes: biogenesis, properties, and evolution of an ancient organelle","volume":"99","author":"D'Alba","year":"2019","journal-title":"Physiol Rev"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms19092668","article-title":"Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact","volume":"19","author":"Del Bino","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV damage in human skin","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem Photobiol"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol Rev"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/exd.12618","article-title":"The role of melanin pigment in melanoma","volume":"24","author":"Slominski","year":"2015","journal-title":"Exp Dermatol"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-540-37696-5_16","article-title":"New perspectives on melanoma pathogenesis and chemoprevention","volume":"174","author":"Meyskens","year":"2007","journal-title":"Recent Results Cancer Res"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/1011-1344(91)80147-A","article-title":"Photoprotection by melanin","volume":"9","author":"Kollias","year":"1991","journal-title":"J Photochem Photobiol B"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Bro\u017cyna","year":"2013","journal-title":"Hum Pathol"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"17844","DOI":"10.18632\/oncotarget.7528","article-title":"Melanin content in melanoma metastases affects the outcome of radiotherapy","volume":"7","author":"Bro\u017cyna","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/00016489.2020.1763456","article-title":"Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck","volume":"140","author":"Guo","year":"2020","journal-title":"Acta Otolaryngol"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1245\/s10434-023-14724-5","article-title":"Factors affecting recurrence and survival for patients with high-risk stage II melanoma","volume":"31","author":"Dedeilia","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/0284186X.2021.1989719","article-title":"A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma","volume":"61","author":"Falkenius","year":"2022","journal-title":"Acta Oncol (Madr)"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamadermatol.2014.1348","article-title":"Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study","volume":"150","author":"Thomas","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2018.04.045","article-title":"Clinically amelanotic or hypomelanotic melanoma: anatomic distribution, risk factors, and survival","volume":"79","author":"Wee","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/CMR.0000000000000571","article-title":"Amelanotic melanoma","volume":"29","author":"Gong","year":"2019","journal-title":"Melanoma Res"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.labinv.2024.102167","article-title":"Deciphering the intricate relationship between macrophages, pigmentation, and prognosis in uveal melanoma","volume":"104","author":"Jha","year":"2024","journal-title":"Lab Invest J Tech Methods Pathol"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"1335333","DOI":"10.3389\/fimmu.2024.1335333","article-title":"Unveiling macrophage diversity in myocardial ischemia-reperfusion injury: identification of a distinct lipid-associated macrophage subset","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Immunol"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/pcmr.13114","article-title":"Histopathologic abundance of pigmentation correlates with disease\u2010specific survival in malignant melanoma but is not independent of current AJCC pT stage","volume":"36","author":"Aebischer","year":"2023","journal-title":"Pigment Cell Melanoma Res"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"100308","DOI":"10.1016\/j.jlb.2025.100308","article-title":"Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation","volume":"9","author":"Noorwali","year":"2025","journal-title":"The J Liquid Biopsy"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2326-6066.CIR-14-0146","article-title":"CD25 identifies a subset of CD4+FoxP3\u2212 TIL that are exhausted yet prognostically favorable in human ovarian cancer","volume":"3","author":"deLeeuw","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12915-025-02237-4","article-title":"Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells","volume":"23","author":"Huang","year":"2025","journal-title":"BMC Biol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.3390\/cancers14205090","article-title":"miR-214-Enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration","volume":"14","author":"Andreucci","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2133.2009.09271.x","article-title":"Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution","volume":"162","author":"Ludgate","year":"2010","journal-title":"Br J Dermatol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2015.08.016","article-title":"A systematic review and meta-analysis of animal-type melanoma","volume":"73","author":"Vyas","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jamadermatol.2019.4912","article-title":"Clinical and dermoscopic features associated with difficult-to-recognize variants of cutaneous melanoma: a systematic review","volume":"156","author":"Pampena","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2559.2006.02411.x","article-title":"Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma","volume":"48","author":"Antony","year":"2006","journal-title":"Histopathology"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PAS.0000000000001195","article-title":"Distinct genomic patterns in pigmented epithelioid Melanocytoma: a molecular and histologic analysis of 16 cases","volume":"43","author":"Isales","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PAS.0000000000001458","article-title":"Genomic and clinicopathologic characteristics of PRKAR1A-inactivated melanomas: toward genetic distinctions of animal-type melanoma\/pigment synthesizing melanoma","volume":"44","author":"Cohen","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000478-200401000-00002","article-title":"Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus","volume":"28","author":"Zembowicz","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaad.2017.01.029","article-title":"Pigmented epithelioid melanocytoma (animal-type melanoma): an institutional experience","volume":"77","author":"Bax","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0046-8177(99)90199-5","article-title":"Malignant melanoma with prominent pigment synthesis: \u201canimal type\u201d melanoma--a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis","volume":"30","author":"Crowson","year":"1999","journal-title":"Hum Pathol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:00:13Z","timestamp":1779310813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003223","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}